136 related articles for article (PubMed ID: 31510826)
1. Ibuprofen treatment after the first days of life in preterm neonates with patent ductus arteriosus.
de Klerk JCA; van Paassen N; van Beynum IM; Flint RB; Reiss IKM; Simons SHP
J Matern Fetal Neonatal Med; 2021 Aug; 34(15):2411-2417. PubMed ID: 31510826
[TBL] [Abstract][Full Text] [Related]
2. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.
El-Mashad AE; El-Mahdy H; El Amrousy D; Elgendy M
Eur J Pediatr; 2017 Feb; 176(2):233-240. PubMed ID: 28004188
[TBL] [Abstract][Full Text] [Related]
4. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
[TBL] [Abstract][Full Text] [Related]
5. Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus.
Engbers AGJ; Flint RB; Völler S; de Klerk JCA; Reiss IKM; Andriessen P; Liem KD; Degraeuwe PLJ; Croubels S; Millecam J; Allegaert K; Simons SHP; Knibbe CAJ
Br J Clin Pharmacol; 2020 Oct; 86(10):2028-2039. PubMed ID: 32250464
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial.
El-Farrash RA; El Shimy MS; El-Sakka AS; Ahmed MG; Abdel-Moez DG
J Matern Fetal Neonatal Med; 2019 Nov; 32(21):3647-3654. PubMed ID: 29695206
[No Abstract] [Full Text] [Related]
7. The Effect of Ibuprofen Exposure and Patient Characteristics on the Closure of the Patent Ductus Arteriosus in Preterm Infants.
Engbers AGJ; Völler S; Flint RB; Goulooze SC; de Klerk J; Krekels EHJ; van Dijk M; Willemsen SP; Reiss IKM; Knibbe CAJ; Simons SHP
Clin Pharmacol Ther; 2022 Aug; 112(2):307-315. PubMed ID: 35429165
[TBL] [Abstract][Full Text] [Related]
8. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
[TBL] [Abstract][Full Text] [Related]
9. Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure.
Roofthooft DW; van Beynum IM; de Klerk JC; van Dijk M; van den Anker JN; Reiss IK; Tibboel D; Simons SH
Eur J Pediatr; 2015 Nov; 174(11):1433-40. PubMed ID: 25922139
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial.
Dani C; Poggi C; Mosca F; Schena F; Lista G; Ramenghi L; Romagnoli C; Salvatori E; Rosignoli MT; Lipone P; Comandini A
Trials; 2016 Apr; 17():182. PubMed ID: 27038924
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants.
De Carolis MP; Romagnoli C; Polimeni V; Piersigilli F; Zecca E; Papacci P; Delogu AB; Tortorolo G
Eur J Pediatr; 2000 May; 159(5):364-8. PubMed ID: 10834523
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
[TBL] [Abstract][Full Text] [Related]
13. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
[TBL] [Abstract][Full Text] [Related]
14. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance.
Dani C; Bertini G; Corsini I; Elia S; Vangi V; Pratesi S; Rubaltelli FF
Acta Paediatr; 2008 Sep; 97(9):1176-80. PubMed ID: 18624987
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Oral High-dose Ibuprofen on Patent Ductus Arteriosus Closure in Preterm Infants.
Pourarian S; Takmil F; Cheriki S; Amoozgar H
Am J Perinatol; 2015 Oct; 32(12):1158-63. PubMed ID: 26007314
[TBL] [Abstract][Full Text] [Related]
16. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.
Ohlsson A; Shah PS
Cochrane Database Syst Rev; 2015 Mar; (3):CD010061. PubMed ID: 25758061
[TBL] [Abstract][Full Text] [Related]
17. Effect on cerebral oxygenation of paracetamol for patent ductus arteriosus in preterm infants.
Dani C; Poggi C; Cianchi I; Corsini I; Vangi V; Pratesi S
Eur J Pediatr; 2018 Apr; 177(4):533-539. PubMed ID: 29372379
[TBL] [Abstract][Full Text] [Related]
18. Comparison of standard versus high-dose ibuprofen for the treatment of hemodynamically significant patent ductus arteriosus in preterm infants.
Hillier K; Jones K; MacInnis M; Mitra S
J Perinatol; 2021 May; 41(5):1142-1148. PubMed ID: 33795792
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study.
Abushanab D; Rouf PA; Al Hail M; Kamal R; Viswanathan B; Parappil H; Elkassem W; Al-Shaibi S; Al-Badriyeh D
Clin Ther; 2021 Feb; 43(2):336-348.e7. PubMed ID: 33431169
[TBL] [Abstract][Full Text] [Related]
20. Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants.
Hsu KH; Wu TW; Wu IH; Lai MY; Hsu SY; Huang HW; Mok TY; Lee CC; Lien R
BMC Pediatr; 2019 Jun; 19(1):179. PubMed ID: 31167645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
